Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 465 entries
View as:

Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin

Phase: N/A Priority: Normal
NCT ID: NCT00210951 Org: User:
Start: 05/31/03 End: 07/31/05 Due: 07/31/06

A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)

Phase: N/A Priority: Normal
NCT ID: NCT00270114 Org: User:
Start: - End: 03/31/91 Due: 03/31/92

Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone

Phase: N/A Priority: Normal
NCT ID: NCT00925457 Org: User:
Start: 03/31/07 End: 03/31/09 Due: 03/31/10

A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

Phase: N/A Priority: Normal
NCT ID: NCT00973141 Org: User:
Start: 09/16/09 End: 06/30/11 Due: 06/30/12

A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00246298 Org: User:
Start: 10/31/05 End: 09/30/06 Due: 09/30/07

A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01273558 Org: User:
Start: 01/31/11 End: 07/31/11 Due: 07/31/12

A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

Phase: N/A Priority: Normal
NCT ID: NCT00210912 Org: User:
Start: 09/30/03 End: 04/30/05 Due: 04/30/06

A Study to Investigate Whether Pharmacokinetic and Pharmacodynamic Interactions Exist Between Metformin and Canagliflozin (JNJ-28431754) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01756417 Org: User:
Start: 10/31/07 End: 11/30/07 Due: 11/30/08

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation

Phase: N/A Priority: Normal
NCT ID: NCT00253214 Org: User:
Start: 03/31/01 End: 07/31/02 Due: 07/31/03

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00035230 Org: User:
Start: 07/31/01 End: 11/30/02 Due: 11/30/03

A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00306267 Org: User:
Start: 03/31/06 End: 05/31/07 Due: 05/31/08

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00299702 Org: User:
Start: 02/28/06 End: 01/31/09 Due: 01/31/10

A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00271453 Org: User:
Start: 02/29/96 End: 10/31/98 Due: 10/31/99

A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02019485 Org: User:
Start: 07/31/10 End: 08/31/10 Due: 08/31/11

A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00602589 Org: User:
Start: 10/31/02 End: 11/30/02 Due: 11/30/03

A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT00662675 Org: User:
Start: 08/31/08 End: 02/28/09 Due: 02/28/10

A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Phase: N/A Priority: Normal
NCT ID: NCT00253162 Org: User:
Start: 03/31/01 End: 09/30/02 Due: 09/30/03

The Effect of Food on the Administration of Canagliflozin in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01343290 Org: User:
Start: 04/30/11 End: 06/30/11 Due: 06/30/12

Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

Phase: N/A Priority: Normal
NCT ID: NCT00709644 Org: User:
Start: 04/30/05 End: 08/31/05 Due: 08/31/06

A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT02049697 Org: User:
Start: 04/30/09 End: 05/31/09 Due: 05/31/10

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01094249 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib

Phase: N/A Priority: Normal
NCT ID: NCT00706953 Org: User:
Start: 07/31/08 End: 06/30/10 Due: 06/30/11

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00236730 Org: User:
Start: 06/30/88 End: 12/31/90 Due: 12/31/91

A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

Phase: N/A Priority: Normal
NCT ID: NCT00236600 Org: User:
Start: 08/31/00 End: 06/30/02 Due: 06/30/03

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

Phase: N/A Priority: Normal
NCT ID: NCT00035191 Org: User:
Start: 10/31/01 End: 09/30/03 Due: 09/30/04